Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LSNE-Leon is a specialized contract development and manufacturing organization (CDMO) that provides sterile fill-finish and lyophilization services for the pharmaceutical and biopharmaceutical industries. Located in Leon, Spain, the facility serves as a strategic hub for clinical and commercial production of complex injectable drug products. The site features advanced manufacturing capabilities, including large-scale lyophilization, aseptic filling, and comprehensive analytical testing. Originally part of Lyophilization Services of New England (LSNE), the facility was integrated into PCI Pharma Services following its acquisition in 2021. It supports a diverse range of therapeutic modalities, including small molecules, biologics, monoclonal antibodies, and vaccines. The Leon facility is known for its expertise in handling oxygen-sensitive and light-sensitive compounds, ensuring high-quality output for global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LSNE-Leon.